These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1928811)

  • 1. Hemodynamic and hemorheologic effects of i.v. Dilevalol in hypertensive patients.
    Pasini FL; Pecchi S; Guideri F; DeFranco V; Damiani P; Galigani C; Saletti M; Verzuri MS; Blardi P; Di Perri T
    Angiology; 1991 Sep; 42(9):703-10. PubMed ID: 1928811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
    Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.
    Fogari R; Poletti L; Tettamanti F; Cesana B; Savonitto S
    G Ital Cardiol; 1990 Apr; 20(4):309-15. PubMed ID: 2197158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
    Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A
    Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.
    Clifton GG; Cook ME; Poland M; Wallin JD
    J Clin Pharmacol; 1989 Jul; 29(7):603-8. PubMed ID: 2760254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
    Soberman J; Greenberg S; Frishman W
    J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dilevalol and propranolol on hemodynamics in patients with essential hypertension.
    Hama J; Oda A; Hirano Y; Horiuchi M; Katori R
    Clin Ther; 1991; 13(4):467-70. PubMed ID: 1933998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of dilevalol in patients with systemic hypertension and left ventricular dysfunction.
    Kinhal V; Kulkarni A; Pozderac R; Cubbon J
    Am J Cardiol; 1989 Jun; 63(19):64I-68I. PubMed ID: 2729126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous dilevalol in the treatment of severe hypertension.
    Bursztyn M; Gavras I; Blasucci DJ; Gavras H
    J Cardiovasc Pharmacol; 1989 May; 13(5):799-802. PubMed ID: 2472530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficacy and safety of dilevalol in the treatment of essential arterial hypertension].
    Bochicchio T; Pérez-Grovas HA; Carrizosa J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1989; 59(2):181-6. PubMed ID: 2569857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring.
    Silagy CA; McNeil JJ; Farish S; McGrath BP
    Br J Clin Pharmacol; 1990 Nov; 30(5):657-64. PubMed ID: 2271366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravenous dilevalol with placebo in moderate hypertension.
    Winer N; Blasucci DJ; Medakovic M
    Clin Pharmacol Ther; 1989 Oct; 46(4):445-50. PubMed ID: 2551560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparison of dilevalol to placebo in patients with mild hypertension.
    Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dilevalol in hypertension assessed by digital pulse plethysmography.
    Takemiya T; Shimizu M; Yamaguti S; Sugishita H; Miuria Y; Yamauti T
    Clin Ther; 1992; 14(3):385-9. PubMed ID: 1638579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension.
    Grossman E; Messerli FH; Oren S; MacPhee AA
    Am J Cardiol; 1989 Jun; 63(19):34I-37I. PubMed ID: 2524958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ; Smith L; Glover DR
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dilevalol on forearm circulation in essential hypertension.
    Giannattasio C; Cleroux J; Seravalle G; Grassi G; Mancia G; Zanchetti A
    Am J Cardiol; 1989 Jun; 63(19):21I-24I. PubMed ID: 2567111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.
    Given BD; Perentesis G; Christopher JD; Herron J; Patrick JE; Kramer WG; Affrime MB
    Am J Cardiol; 1989 Jun; 63(19):12I-16I. PubMed ID: 2729123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacodynamics of dilevalol.
    Riddell JG
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():39-44. PubMed ID: 2370642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of clinical trials of dilevalol in essential hypertension.
    Glover DR; Tarbit WJ
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():49-53. PubMed ID: 2142508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.